MENU
+Compare
GLAXF
Stock ticker: OTC
AS OF
Jan 13 closing price
Price
$25.00
Change
-$0.35 (-1.38%)
Capitalization
101.95B

GLAXF stock forecast, quote, news & analysis

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales... Show more

GLAXF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for GLAXF with price predictions
Jan 12, 2026

Momentum Indicator for GLAXF turns positive, indicating new upward trend

GLAXF saw its Momentum Indicator move above the 0 level on January 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 143 similar instances where the indicator turned positive. In of the 143 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for GLAXF just turned positive on January 06, 2026. Looking at past instances where GLAXF's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GLAXF advanced for three days, in of 165 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 210 cases where GLAXF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

GLAXF broke above its upper Bollinger Band on January 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.638) is normal, around the industry mean (9.614). P/E Ratio (13.961) is within average values for comparable stocks, (24.704). Projected Growth (PEG Ratio) (0.429) is also within normal values, averaging (2.019). Dividend Yield (0.034) settles around the average of (0.025) among similar stocks. P/S Ratio (2.388) is also within normal values, averaging (3.974).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GLAXF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Dividends

GLAXF paid dividends on October 07, 2021

GSK plc GLAXF Stock Dividends
А dividend of $0.23 per share was paid with a record date of October 07, 2021, and an ex-dividend date of August 19, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 111.6B. The market cap for tickers in the group ranges from 72.83K to 964.11B. LLY holds the highest valuation in this group at 964.11B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 16%. CHJTF experienced the highest price growth at 26%, while MDCX experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -10%. For the same stocks of the Industry, the average monthly volume growth was 9% and the average quarterly volume growth was 11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 29
P/E Growth Rating: 64
Price Growth Rating: 47
SMR Rating: 55
Profit Risk Rating: 72
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
GLAXF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
980 Great West Road
Phone
+44 2080475000
Employees
70212
Web
https://www.gsk.com